

Squawk on the Street
CNBC
CNBC’s “Squawk on the Street” with Carl Quintanilla, Jim Cramer and David Faber is broadcast from the floor of the New York Stock Exchange, on site at the opening bell with the up-to-the-minute news investors need to know and interviews with the most influential Chief Executive Officers and greatest market minds.
Episodes
Mentioned books

Dec 20, 2024 • 49min
SOTS 2nd Hour: Chicago Fed President Goolsbee, FedEx's Freight Spinoff, Nike's Turnaround Plan 12/20/24
Join Austan Goolsbee, President of the Chicago Fed, as he shares his insights on the latest economic data and the Fed's interest rate outlook. He predicts a judicious decline in rates by 2025, sparking market optimism. Meanwhile, Steve Liesman dives into FedEx's promising earnings and a strategic spinoff of its freight business, while exploring Nike's efforts to rebound under new CEO Elliott Hill amid ongoing challenges. Tune in for a blend of economic analysis and corporate strategies!

Dec 20, 2024 • 43min
Markets and Inflation, Shutdown Deadline Looms, FedEx Spinoff Plans, Nike’s Turnaround Push 12/20/24
The discussion dives into market reactions to inflation data and a looming government shutdown. FedEx's plan to spin off its freight business contrasts with Nike's efforts to bounce back. Political turmoil adds to market volatility, with speculations swirling around key players like Trump and Musk. A sharp drop in Novo Nordisk shares highlights the drug trial challenge, while bitcoin struggles this week. Insights into small business resilience and significant debt issues facing CVS and Intel round out the conversation.

Dec 19, 2024 • 42min
SOTS 2nd Hour: Stocks Bounce Back, Musk's DC Chaos, Live: Accenture CEO 12/19/24
Julie Sweet, CEO of Accenture, shares insights on the company’s impressive quarterly results, which have boosted their stock price. The chat highlights the market rebound following a rough patch influenced by the Fed's rate outlook. Sweet also discusses the transformative power of generative AI in government and business, showcasing Accenture's innovative strategies to enhance efficiency and revenue growth. Additionally, the political landscape is examined with a looming government shutdown, featuring commentary from Elon Musk and Trump.

Dec 19, 2024 • 43min
Morning After the Sell-off, Micron Tumbles, Trump: Abolish the Debt Ceiling 12/19/24
The hosts dive into the fallout from a major market sell-off, questioning the Fed's recent decisions. Micron's stock plummets despite a solid earnings report, stirring investor concern. Trump advocates for abolishing the debt ceiling, igniting political debate. They discuss Elon Musk's influence on a critical bipartisan spending deal. Meanwhile, Darden Restaurants shines with strong earnings, while Lamb Weston experiences a sharp decline after executive changes. The conversation touches on retail dynamics and evolving economic signals, keeping listeners on their toes.

Dec 18, 2024 • 43min
2nd Hour: Countdown to the Fed, Salesforce CEO Marc Benioff, Housing Outlook for 2025 12/18/24
Marc Benioff, the visionary CEO of Salesforce, shares his excitement about the company’s plan to hire 2,000 talent to sell AI products. He emphasizes how this innovation represents a peak moment in his career. Alongside, insights are offered about the housing market outlook for 2025, highlighting the potential effects of Federal Reserve policies on this sector. The discussion touches on the impacts of advanced AI technologies and the competitive landscape, showcasing the transformative role of Salesforce’s Agent Force 2.0 in enhancing customer interactions.

Dec 18, 2024 • 3min
Cramer's Morning Take: Fed Preview, Best Buy 12/18/24
Expectations rise for a pivotal Federal Reserve meeting, hinting at a potential interest rate cut. Analysts are bullish on Best Buy, examining its adaptability in a challenging economic landscape. The conversation spotlights Best Buy's smart pricing strategies and the burgeoning consumer electronics market. Additionally, the potential impact of tariffs on sales is discussed, alongside the importance of expert setup services that enhance consumer convenience amidst changing market dynamics.

Dec 18, 2024 • 43min
Fed Decision Day, Nvidia Rebounds, Starbucks CEO's 100th Day on the Job 12/18/24
Market dynamics take center stage as experts parse the implications of the Federal Reserve's upcoming interest rate decision. Nvidia bounces back, sparking discussions around stock corrections. The new Starbucks CEO reflects on his initial 100 days amid labor challenges and stock performance woes. Meanwhile, merger talks between Honda and Nissan heat up, with Morgan Stanley selecting Disney as a top pick for 2025. Plus, a focus on the record-setting 'Magnificent 7' stocks and the Dow's notable losing streak adds to the financial drama.

Dec 17, 2024 • 3min
Cramer's Morning Take: Broadcom 12/17/24
Cramer discusses the recent 38% surge in Broadcom's stock and the Club's decision to cash in on those gains. Insights from the CEO provide an optimistic outlook on market opportunities. The conversation underscores the need for disciplined stock management, especially in the tech sector. Key players like NVIDIA, Broadcom, and AMD are analyzed, offering valuable strategies for investors navigating this competitive landscape.

Dec 17, 2024 • 44min
SOTS 2nd Hour: Nvidia in Correction Territory, Trump Takes Aim at PBMs, CNBC Fed Survey 12/17/24
Vamil Devan, a Guggenheim Securities analyst specializing in the pharmaceutical sector, dives into pressing market dynamics. He discusses Nvidia's alarming plunge into correction territory and its implications for investors. Devan also analyzes President-elect Trump’s critique of pharmacy benefit managers, poised to reshape drug pricing strategies. With insights on Pfizer’s future amidst market pressures and evolving healthcare innovations, the conversation highlights a cautious outlook for major health companies facing heightened scrutiny.

Dec 17, 2024 • 43min
Nvidia Correction, Tesla Extends Record Run, Trump Comments Cause Pain for Health Insurers 12/17/24
Nvidia is facing a significant correction, down over 10% from its peak, while Tesla is soaring to new heights thanks to an upgrade. President-elect Trump's drug pricing comments are causing turbulence for major health insurers. The team dives into the implications of the Fed's upcoming decisions and assesses the overall market landscape. There's also buzz around Databricks securing major funding, and discussions on the evolving pharmaceutical and tech sectors paired with insights on self-driving technologies.


